Kalmanti M - Search Results

1

Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy.

Dimitriou H, Stiakaki E, Markaki EA, Bolonaki I, Giannakopoulou C, Kalmanti M. Dimitriou H, et al. Among authors: kalmanti m. Acta Paediatr. 2000 Oct;89(10):1169-73. doi: 10.1080/080352500750027510. Acta Paediatr. 2000. PMID: 11083370

2

Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.

Perdikogianni Ch, Dimitriou H, Stiakaki E, Markaki EA, Kalmanti M. Perdikogianni Ch, et al. Among authors: kalmanti m. Acta Paediatr. 2003 Nov;92(11):1277-83. doi: 10.1080/08035250310005693. Acta Paediatr. 2003. PMID: 14696847

3

Management of childhood diseases during the Byzantine period: III-- respiratory diseases of childhood.

Ramoutsaki IA, Dimitriou H, Markaki EA, Kalmanti M. Ramoutsaki IA, et al. Among authors: kalmanti m. Pediatr Int. 2002 Aug;44(4):460-2. doi: 10.1046/j.1442-200x.2002.01574.x. Pediatr Int. 2002. PMID: 12139580

4

Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.

Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T. Kalmanti M, et al. Int J Hematol. 1993 Apr;57(2):147-52. Int J Hematol. 1993. PMID: 8494993

5

Treatment with recombinant human erythropoietin in children with malignancies.

Bolonaki I, Stiakaki E, Lydaki E, Dimitriou H, Kambourakis A, Kalmantis T, Kalmanti M. Bolonaki I, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 1996 Mar-Apr;13(2):111-21. doi: 10.3109/08880019609030801. Pediatr Hematol Oncol. 1996. PMID: 8721025 Clinical Trial.

6

Isolated intracranial metastasis of neuroblastoma 2 years after completion of therapy.

Lydaki E, Bolonaki I, Stiakaki E, Dini G, Kalmanti M. Lydaki E, et al. Among authors: kalmanti m. Acta Paediatr Jpn. 1997 Feb;39(1):79-82. doi: 10.1111/j.1442-200x.1997.tb03561.x. Acta Paediatr Jpn. 1997. PMID: 9124060

7

Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.

Giannakopoulou C, Bolonaki I, Stiakaki E, Dimitriou H, Galanaki H, Hatzidaki E, Kalmanti M. Giannakopoulou C, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):37-43. doi: 10.3109/08880019809009506. Pediatr Hematol Oncol. 1998. PMID: 9509504 Clinical Trial.

8

Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.

Stiakaki E, Savvas S, Lydaki E, Bolonaki I, Kouvidi E, Dimitriou H, Kambourakis A, Kalmanti M. Stiakaki E, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 1999 Mar-Apr;16(2):101-8. doi: 10.1080/088800199277425. Pediatr Hematol Oncol. 1999. PMID: 10100270 Clinical Trial.

9

Reed-Sternberg cells in atypical primary EBV infection.

Bitsori M, Stiakaki E, Tzardi M, Kalmanti M. Bitsori M, et al. Among authors: kalmanti m. Acta Paediatr. 2001 Feb;90(2):227-9. doi: 10.1080/080352501300049569. Acta Paediatr. 2001. PMID: 11236057

10

Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma.

Markaki EA, Tsopanomichalou M, Dimitriou H, Stiakaki E, Perdikoyanni C, Spandidos D, Kalmanti M. Markaki EA, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 2001 Mar;18(2):101-10. doi: 10.1080/088800101300002928. Pediatr Hematol Oncol. 2001. PMID: 11255727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters